Apellis Pharmaceuticals, Inc. Common Stock (APLS) — Analysis Summary
Apellis Pharmaceuticals, Inc. Common Stock (APLS) has a market cap of $5.24B with year-over-year revenue growth of +97.0%. Net margin stands at -25.3%. The stock trades at a P/E ratio of -26.5.
Key Takeaways
- Revenue changed +97.0% year-over-year
- Net margin of -25.3%
- P/E ratio of -26.5
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, APLS posted revenue growth of +97.0% and trades at a P/E of -26.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.